SLGL
NASD Sol-Gel Technologies Ltd.$68.30 ↑ +0.00 (+0.00%) Trading Up from the previous close of $68.30, $4.51 below the day’s high of $72.81
- YTD change
- +62.08%
- vs 20-day SMA
- +0.30%
- vs 200-day SMA
- -6.22%
Price ranges
Price & Performance
-6.11 (-8.21%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 67.5% away from all-time highs of $210.00
- SLGL is up 62% since the beginning of the year
- SLGL is up 71% over the past 12 months
- SLGL is up 5% over the past 1 month
- 5% of all SLGL investors are betting against SLGL
SLGL reads not so good: price sits above one of the two key moving averages, the 12-month move is +71.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -13.49%
- vs 8-day SMA
- -6.76%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.